Allscripts Healthcare Solutions, Inc. - common stock (MDRX) Social Stream



Allscripts Healthcare Solutions, Inc. - common stock (MDRX): $17.21

0.10 (+0.58%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Allscripts Healthcare Solutions Inc (MDRX) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering MDRX.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
11 $22 $16 $18.777 $18.26 2.83%
11 $22 $16 $18.555 $18.26 1.62%
12 $22 $16 $18.3 $18.26 0.22%

The Trend in the Analyst Price Target


Over the past 19 months, MDRX's average price target has gone up $10.71.

Over the past 19 months, MDRX's average upside potential has been -0.19%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-12-14 11 22 16 18.777 17.63 6.51%
2020-05-29 22 12 6 8.070 NA NA%

MDRX Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2.45 3 2 5 1 1 11

The Trend in the Broker Recommendations


Over the past 21 months, MDRX's average broker recommendation rating worsened by 0.02.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • MDRX has a higher upside potential (average analyst target price relative to current price) than 45.54% of all US stocks.
  • MDRX has a higher number of analysts covering the stock than 262.09% of stocks in the mid market cap category.
  • MDRX has a higher average analyst price target than 55.03% of stocks in the mid market cap category.
  • The variance in analysts' estimates of MDRX is less than -7.15000000000001% of Technology stocks.

Stocks similar to Allscripts Healthcare Solutions Inc in the Computers industry regarding analyst recommendations and price targets are MNDT, JNPR and FFIV.

Make investment decisions regarding MDRX using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.7971 seconds.